日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Escherichia coli O8 Protein TolB (tolB) CSB-YP484317EOO
CSB-EP484317EOO
CSB-BP484317EOO
CSB-MP484317EOO
CSB-EP484317EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Penicillin-insensitive murein endopeptidase (mepA) CSB-YP484318EOO
CSB-EP484318EOO
CSB-BP484318EOO
CSB-MP484318EOO
CSB-EP484318EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Manganese transport protein MntH (mntH), partial CSB-YP484319EOO
CSB-EP484319EOO
CSB-BP484319EOO
CSB-MP484319EOO
CSB-EP484319EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Rhamnulose-1-phosphate aldolase (rhaD) CSB-YP484320EOO
CSB-EP484320EOO
CSB-BP484320EOO
CSB-MP484320EOO
CSB-EP484320EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP484321EOO
CSB-EP484321EOO
CSB-BP484321EOO
CSB-MP484321EOO
CSB-EP484321EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Acetylglutamate kinase (argB) CSB-YP484322EOO
CSB-EP484322EOO
CSB-BP484322EOO
CSB-MP484322EOO
CSB-EP484322EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 50S ribosomal protein L1 (rplA) CSB-YP484323EOO
CSB-EP484323EOO
CSB-BP484323EOO
CSB-MP484323EOO
CSB-EP484323EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 UPF0194 membrane protein ybhG (ybhG) CSB-YP484324EOO
CSB-EP484324EOO
CSB-BP484324EOO
CSB-MP484324EOO
CSB-EP484324EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 23S rRNA (uracil (747)-C (5))-methyltransferase RlmC CSB-YP484325EOO
CSB-EP484325EOO
CSB-BP484325EOO
CSB-MP484325EOO
CSB-EP484325EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Dihydrodipicolinate synthase (dapA) CSB-YP484326EOO
CSB-EP484326EOO
CSB-BP484326EOO
CSB-MP484326EOO
CSB-EP484326EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 GTPase Der (der) CSB-YP484327EOO
CSB-EP484327EOO
CSB-BP484327EOO
CSB-MP484327EOO
CSB-EP484327EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Peptidase B (pepB) CSB-YP484328EOO
CSB-EP484328EOO
CSB-BP484328EOO
CSB-MP484328EOO
CSB-EP484328EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 3-phenylpropionate/cinnamic acid dioxygenase subunit beta (hcaF) CSB-YP484329EOO
CSB-EP484329EOO
CSB-BP484329EOO
CSB-MP484329EOO
CSB-EP484329EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Leucyl/phenylalanyl-tRNA--protein transferase (aat) CSB-YP484330EOO
CSB-EP484330EOO
CSB-BP484330EOO
CSB-MP484330EOO
CSB-EP484330EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Integration host factor subunit beta (ihfB) CSB-YP484331EOO
CSB-EP484331EOO
CSB-BP484331EOO
CSB-MP484331EOO
CSB-EP484331EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Alkanesulfonate monooxygenase (ssuD) CSB-YP484332EOO
CSB-EP484332EOO
CSB-BP484332EOO
CSB-MP484332EOO
CSB-EP484332EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 UPF0319 protein YccT (yccT) CSB-YP484333EOO
CSB-EP484333EOO
CSB-BP484333EOO
CSB-MP484333EOO
CSB-EP484333EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Divalent-cation tolerance protein CutA (cutA) CSB-YP484334EOO
CSB-EP484334EOO
CSB-BP484334EOO
CSB-MP484334EOO
CSB-EP484334EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 3-keto-L-gulonate-6-phosphate decarboxylase UlaD (ulaD) CSB-YP484335EOO
CSB-EP484335EOO
CSB-BP484335EOO
CSB-MP484335EOO
CSB-EP484335EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Flavoprotein wrbA (wrbA) CSB-YP484336EOO
CSB-EP484336EOO
CSB-BP484336EOO
CSB-MP484336EOO
CSB-EP484336EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×